1. From the Department of Vascular Biology and Thrombosis Research (F.G., B.R.B., R.d.M.), the Clinical Institute of Medical and Chemical Laboratory Diagnostics, and Ludwig Boltzmann Institute of Clinical Experimental Oncology (M.B., O.W.), University of Vienna, Austria; and the Competence Center Biomolecular Therapeutics GmbH (H.M., V.K.), Vienna, Austria.